Finance

Beta
Lists
MAIA:NYSEAMERICAN
Maia Biotechnology Inc
$1.36
+2.64%
(+0.035) 1D
Jun 17, 11:57:28 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MAIA...
Open
$1.31
High
$1.36
Low
$1.31
Mkt. cap
82.69M
Avg. vol.
851.78K
Volume
182.00K
52-wk high
$3.19
52-wk low
$0.87
EPS
-$0.68
Beta
0.23
Shares outstanding
60.80M
No. of employees
13
Open
$1.31
High
$1.36
Low
$1.31
Mkt. cap
82.69M
Avg. vol.
851.78K
Volume
182.00K
52-wk high
$3.19
52-wk low
$0.87
EPS
-$0.68
Beta
0.23
Shares outstanding
60.80M
No. of employees
13
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to MAIA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for MAIA in the last 3 months.
Highest
Current $1.36
$14.00 (+929.41%)
Average
$14.00 (+929.41%)
Lowest
$14.00 (+929.41%)
News stories
From sources across the web
Profile
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
About Maia Biotechnology Inc
CEO-
Employees13
Founded2018
HeadquartersChicago, Illinois, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.11M
6.36M
1.88M
3.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.06M
3.00M
2.44M
3.42M
Operating expense
5.17M
9.36M
4.32M
6.95M
Total operating expenses
5.17M
9.36M
4.32M
6.95M
Operating income
-5.17M
-9.36M
-4.32M
-6.95M
Other non operating income
-260.60K
379.31K
614.86K
468.52K
EBT including unusual items
-5.35M
-8.90M
-3.63M
-6.37M
EBT excluding unusual items
-5.35M
-8.90M
-3.63M
-6.37M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.35M
-8.90M
-3.63M
-6.37M
Net profit margin
-
-
-
-
Earnings per share
-0.17
-0.27
-0.14
-0.14
Interest and investment income
79.70K
78.43K
73.65K
111.76K
Interest expense
-
-
-
-
Net interest expenses
79.70K
78.43K
73.65K
111.76K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more